STARGEN
USPTO Trademark Record · Serial No. 77252613
Trademark details
It was initially claimed by Oxford Biomedica Plc on 20070810.
That brand applies to the following goods and services:Gene therapy and prophylaxis products, namely, proteins, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic and angiogenic molecules, all for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eyes; pharmaceutical preparations for treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eye; retroviral vector and retroviral vector manufacturing prep, Scientific and medical research and development in respect of diseases of the eye; genetic engineering services; biotechnology services, relating to gene therapy products, namely, development of new technology for others in the field of biotechnology and medical research, namely, development of new technologies for others for diagnosis and treatment of diseases of the eyes, Licensing of intellectual property in respect of gene therapy products.
Currently that trademark is represented by trademark attorney(s): Roberta S. Bren.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the STARGEN trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
